Access the full text.
Sign up today, get DeepDyve free for 14 days.
Rea (1976)
107Br J Prevent Social Med, 30
Johnson Johnson (1977)
Prevalence of dermatologic disease among persons 1–74 years of age in the United StatesAdvance Data from Vital and Health Statistics of the National Center for Health Statistics
J. Berth‐Jones, P. Hutchinson (1992)
Vitamin D analogues and psoriasisBritish Journal of Dermatology, 127
Ford Ford, Burr Burr (1979)
Simonsen M. A lymph node assay for the graft‐versus‐host activity of rat lymphoid cellsTransplantation, 10
C. Griffiths, A. Powles, J. Leonard, L. Fry, B. Baker, H. Valdimarsson (1986)
Clearance of psoriasis with low dose cyclosporin.British Medical Journal (Clinical research ed.), 293
C. Griffiths, A. Powles, J. McFadden, B. Baker, Helgi Valdimarsson, Lionel Fry (1989)
Long‐term cyclosporin for psoriasisBritish Journal of Dermatology, 120
I. Lelis (1980)
[Atopic dermatitis].Vestnik dermatologii i venerologii, 8
Leent Leent, Gräber Gräber, Thurston Thurston (1997)
Topical treatment with the macrolactam SDZ ASM 981 is effective in atopic dermatitisAustralasian J Dermatol, 38
C. Griffiths, J. Voorhees, B. Nickoloff (1989)
Gamma interferon induces different keratinocyte cellular patterns of expression of HLA‐DR and DQ and intercellular adhesion molecule‐I (ICAM‐I) antigensBritish Journal of Dermatology, 120
(1994)
ct»/. Topical activity of the immunosuppressive macrolide SDZ 281-240 in animal models of allergic contact dermatitis (abstract
Rajka Rajka (1986)
Natural history and clinical manifestations of atopic eczemaClin Rev Allergy, 4
J. Ross, R. Camp (1990)
Cyclosporin A in atopic dermatitisBritish Journal of Dermatology, 122
Saurat Saurat (1987)
Dermatite atopique de l'enfantAnn Nestle, 45
K. Ho, F. Powell (1992)
(35) Dowling‐Degos disease with rosacealike eruption (Haber's syndrome)British Journal of Dermatology, 127
(1997)
Topical treatment with the anti-inilammatory macroladam SDZ ASM 981 suppresses plaque-type psoriasis. Australasian / Dermatoi
Y. Prost, C. Bodemer, D. Teillac (1989)
Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis.Acta dermato-venereologica. Supplementum, 144
(1997)
, Thurston . M el al Topical treatment with the maeroliictam SDZ ASM 981 is effective in alopic dermatitis
US \ational Heallh Survey 1971-74
C. Surber, P. Itin, S. Büchner (1992)
Clinical controversy on the effect of topical ciclosporin: what is the target site?Dermatology, 185 4
C. Griffiths, A. Powles, B. Baker, L. Fry, H. Valdimarsson (1987)
TOPICAL CYCLOSPORIN AND PSORIASISThe Lancet, 329
F. Larsen (1993)
The epidemiology of atopic dermatitis.Monographs in allergy, 31
(1992)
Druy reactions. In: Textbook of Denuatolotjn (Champion RH. Burlon )[
M. Rie, M. Meinardi, J. Bos (1991)
Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis.Acta dermato-venereologica, 71 5
J. Meingassner, A. Stütz (1992)
Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?The Journal of investigative dermatology, 98 6
K. Rappersberger, J. Meingassner, R. Fialla, D. Födinger, B. Sterniczky, Silvia Rauch, E. Putz, A. Stütz, K. Wolff (1996)
Clearing of psoriasis by a novel immunosuppressive macrolide.The Journal of investigative dermatology, 106 4
W. Ford, W. Burr, M. Simonsen (1970)
A LYMPH NODE WEIGHT ASSAY FOR THE GRAFTVERSUS- HOST ACTIVITY OF RAT LYMPHOID CELLSTransplantation, 10
J. Smitt, D. Winterberg (1992)
Topical Corticosteroids in Children: Local and Systemic Effects
U. Mrowietz (1992)
The enigma of cyclosporin A treatment for psoriasis: systemic efficacy versus topical non-responsiveness. A review.Acta dermato-venereologica, 72 5
M. Mihatsch, K. Wolff (1992)
Consensus Conference on cyclosporin A for psoriasis February 1992British Journal of Dermatology, 126
G. Rajka (1986)
Natural history and clinical manifestations of atopic dermatitisClinical Reviews in Allergy, 4
(1997)
SDZ ASM 981 - a novel antiintlammatory macrolactam - does not induce skin atrophy
L. Hellgren (1967)
Psoriasis : The prevalence in sex, age and occupational groups in total populations in Sweden. Morphology, inheritance and association with other skin and rheumatic diseases
Griffiths Griffiths, Powles Powles, Baker Baker (1987)
Topical cyclosporin and psoriasis (letter)Lancet, i
Mrowietz Mrowietz, Bräutigam Bräutigam, Gräber Gräber (1997)
Topical treatment with the anti‐inflammatory macrolactam SDZ ASM 981 suppresses plaque‐type psoriasisAustralasian J Dermatol, 38
MEINGASSNER el itl
Queille‐Roussel Queille‐Roussel, Graeber Graeber, Wagenaar Wagenaar (1997)
Topical treatment with the anti‐inflammatory macrolactam SDZ ASM 981 inhibits established nickel contact dermatitisAustralasian J Dermatol, 38
(1987)
Dermatitc alopique dc I ' difatit
Hellgren (1976)
19
T. Joost, F. Heule, E. Stolz, R. Beukers (1986)
Short‐term use of cyclosporin A in severe psoriasisBritish Journal of Dermatology, 114
Rea Rea, Newhouse Newhouse, Halil Halil (1976)
Skin disease in LambethBr J Prevent Social Med, 30
C. Ellis, D. Gorsulowsky, T. Hamilton, J. Billings, Marc Brown, J. Headington, K. Cooper, O. Baadsgaard, E. Duell, T. Annesley, J. Turcotte, J. Voorhees (1986)
Cyclosporine improves psoriasis in a double-blind study.JAMA, 256 22
E. Bywaters (1976)
Disorders of Connective TissuesAnnals of the Rheumatic Diseases, 35
T. Joost, E. Stolz, F. Heule (1987)
Efficacy of low-dose cyclosporine in severe atopic skin disease.Archives of dermatology, 123 2
J. Sowden, J. Berth‐Jones, J. Ross, R. Motley, Ronald Marks, Andrew Finlay, Mir-saeed Salek, R. Graham‐Brown, B. Allen, Richard Camp (1991)
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 338
(1977)
Previilence of dermatologic iliseuse among persons 1-74 years of age in the ilnileil States. Adviiiwc Dntu fwin Vitiil iinil Henlth StiUistirs oj the Satioiui! Cciitei-fni- Hviiltli StiUistiis
R. Marks (1992)
Adverse Side Effects from the Use of Topical Corticosteroids
(1977)
Previilence of dermatologic iliseuse among persons 174 years of age in the ilnileil States
D. Groisser, C. Griffiths, C. Ellis, J. Voorhees (1991)
A review and update of the clinical uses of cyclosporine in dermatology.Dermatologic clinics, 9 4
Maibach HI . Adverse systemic effects of topical eorticnids
E. Higgins, J. Mclelland, P. Friedmann, J. Matthews, S. Shuster (1991)
Oral cyclosporin inhibits the expression of contact hypersensitivity in man.Journal of dermatological science, 2 2
Summary There is a need for safe and effective therapies for inflammatory skin diseases. Current topical and systemic treatment of psoriasis is effective but suffers from side‐effects or is inconvenient. The therapeutic armamentarium for atopic dermatitis is very limited and far from satisfactory. In vivo preclinical data are presented for SDZ ASM 981, a novel ascomycin macrolactam derivative with high anti‐inflammatory activity. Anti‐inflammatory activity was observed in mouse, rat and pig models of allergic contact dermatitis. In the pig model, topical SDZ ASM 981 was as effective as the ultrapotent corticosteroid clobetasol‐17‐propionate, and when compared with a series of commercial topical corticosteroid preparations, 0·1% SDZ ASM 981 had equivalent efficacy to clobetasol‐17‐propionate (0·05%), the most potent product on the market. Unlike the corticosteroid, however, SDZ ASM 981 did not cause skin atrophy in pigs. SDZ ASM 981 potently inhibited allergic contact dermatitis in mice and rats when given systemically, and oral treatment was more effective than cyclosporin A in rats. Furthermore, SDZ ASM 981 has a low potential for affecting systemic immune responses, as demonstrated in rat models of localized graft vs. host reaction and allogeneic kidney transplantation. Preclinical results suggest that SDZ ASM 981 has the potential to be a well‐tolerated and effective drug for topical as well as oral treatment of inflammatory skin diseases.
British Journal of Dermatology – Wiley
Published: Oct 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.